111 related articles for article (PubMed ID: 38723105)
1. Type B thymomas in patients with myasthenia gravis display a distinctive pattern of αβ TCR and IL-7 receptor α expression on CD4
Wang T; Wang B; Fan X; Cai Y; Li L; Fu S
Autoimmunity; 2024 Apr; 57(1):2347379. PubMed ID: 38723105
[TBL] [Abstract][Full Text] [Related]
2. Two-color flow cytometric analysis of thymic lymphocytes from patients with myasthenia gravis and/or thymoma.
Ichikawa Y; Shimizu H; Yoshida M; Arimori S
Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):91-6. PubMed ID: 1370261
[TBL] [Abstract][Full Text] [Related]
3. Role of positive selection of thymoma-associated T cells in the pathogenesis of myasthenia gravis.
Inada K; Okumura M; Shiono H; Inoue M; Kadota Y; Ohta M; Matsuda H
J Surg Res; 2005 Jun; 126(1):34-40. PubMed ID: 15916972
[TBL] [Abstract][Full Text] [Related]
4. Mature CD4 single positive thymocytes in human Thymoma: T cells may differentiate in the thymic epithelial cell tumor.
Inoue M; Fujii Y; Okumura M; Takeuchi Y; Shiono H; Miyoshi S; Matsuda H; Shirakura R
Pathobiology; 1997; 65(4):216-22. PubMed ID: 9396046
[TBL] [Abstract][Full Text] [Related]
5. [Abnormal T cell maturation in myasthenia gravis associated thymomas].
Nenninger R; Schultz A; Müller-Hermelink HK; Marx A
Verh Dtsch Ges Pathol; 1996; 80():256-60. PubMed ID: 9065022
[TBL] [Abstract][Full Text] [Related]
6. Thymopoiesis, regulatory T cells, and TCRVbeta expression in thymoma with and without myasthenia gravis, and modulatory effects of steroid therapy.
Fattorossi A; Battaglia A; Buzzonetti A; Minicuci G; Riso R; Peri L; Scambia G; Evoli A
J Clin Immunol; 2008 Mar; 28(2):194-206. PubMed ID: 18000743
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic myasthenia gravis correlates with generation of mature naive CD4(+) T cells in thymomas.
Ströbel P; Helmreich M; Menioudakis G; Lewin SR; Rüdiger T; Bauer A; Hoffacker V; Gold R; Nix W; Schalke B; Elert O; Semik M; Müller-Hermelink HK; Marx A
Blood; 2002 Jul; 100(1):159-66. PubMed ID: 12070022
[TBL] [Abstract][Full Text] [Related]
8. Decreased frequency of intrathymic regulatory T cells in patients with myasthenia-associated thymoma.
Luther C; Poeschel S; Varga M; Melms A; Tolosa E
J Neuroimmunol; 2005 Jul; 164(1-2):124-8. PubMed ID: 15923045
[TBL] [Abstract][Full Text] [Related]
9. Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis.
Buckley C; Douek D; Newsom-Davis J; Vincent A; Willcox N
Ann Neurol; 2001 Jul; 50(1):64-72. PubMed ID: 11456312
[TBL] [Abstract][Full Text] [Related]
10. Progressive peripheral CD8
Tabata R; Tabata C; Yamamoto N; Shibuya S; Yasumizu R; Kojima M
Int Immunopharmacol; 2018 Oct; 63():14-18. PubMed ID: 30056258
[TBL] [Abstract][Full Text] [Related]
11. Pathomechanisms of paraneoplastic myasthenia gravis.
Ströbel P; Preisshofen T; Helmreich M; Müller-Hermelink HK; Marx A
Clin Dev Immunol; 2003 Mar; 10(1):7-12. PubMed ID: 14575152
[TBL] [Abstract][Full Text] [Related]
12. [Expression of CD20 in thymomas and its clinical implication].
Du J; Zhou XJ; Yin HL; Lu ZF; Zhou HB
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):611-4. PubMed ID: 21092589
[TBL] [Abstract][Full Text] [Related]
13. Abnormal thymocyte development and generation of autoreactive T cells in mixed and cortical thymomas.
Nenninger R; Schultz A; Hoffacker V; Helmreich M; Wilisch A; Vandekerckhove B; Hünig T; Schalke B; Schneider C; Tzartos S; Kalbacher H; Müller-Hermelink HK; Marx A
Lab Invest; 1998 Jun; 78(6):743-53. PubMed ID: 9645765
[TBL] [Abstract][Full Text] [Related]
14. [Histological studies of thymomas from 17 myasthenia gravis and 1 pure red cell aplasia patients and the T cell subsets before and after in vitro culture with rIL-2].
Takiguchi T
Arerugi; 1993 May; 42(5):665-75. PubMed ID: 8323466
[TBL] [Abstract][Full Text] [Related]
15. Development of innate CD4+ and CD8+ T cells in Itk-deficient mice is regulated by distinct pathways.
Prince AL; Kraus Z; Carty SA; Ng C; Yin CC; Jordan MS; Schwartzberg PL; Berg LJ
J Immunol; 2014 Jul; 193(2):688-99. PubMed ID: 24943215
[TBL] [Abstract][Full Text] [Related]
16. T-cell development in human thymoma.
Inoue M; Fujii Y; Okumura M; Miyoshi S; Shiono H; Fukuhara K; Kadota Y; Matsuda H
Pathol Res Pract; 1999; 195(8):541-7. PubMed ID: 10483584
[TBL] [Abstract][Full Text] [Related]
17. Expanded TCR Vbeta subsets of CD8(+) T-cells in late-onset myasthenia gravis: novel parallels with thymoma patients.
Tackenberg B; Schlegel K; Happel M; Eienbröker C; Gellert K; Oertel WH; Meager A; Willcox N; Sommer N
J Neuroimmunol; 2009 Nov; 216(1-2):85-91. PubMed ID: 19781791
[TBL] [Abstract][Full Text] [Related]
18. The PTPN22gain-of-function+1858T(+) genotypes correlate with low IL-2 expression in thymomas and predispose to myasthenia gravis.
Chuang WY; Ströbel P; Belharazem D; Rieckmann P; Toyka KV; Nix W; Schalke B; Gold R; Kiefer R; Klinker E; Opitz A; Inoue M; Kuo TT; Müller-Hermelink HK; Marx A
Genes Immun; 2009 Dec; 10(8):667-72. PubMed ID: 19693092
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of Th1-type chemokine receptor CXCR3 on CD4+ T cells in myasthenia gravis patients.
Suzuki Y; Onodera H; Tago H; Saito R; Ohuchi M; Shimizu M; Matsumura Y; Kondo T; Yoshie O; Itoyama Y
J Neuroimmunol; 2006 Mar; 172(1-2):166-74. PubMed ID: 16427705
[TBL] [Abstract][Full Text] [Related]
20. Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease.
Hoffacker V; Schultz A; Tiesinga JJ; Gold R; Schalke B; Nix W; Kiefer R; Müller-Hermelink HK; Marx A
Blood; 2000 Dec; 96(12):3872-9. PubMed ID: 11090072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
